Simulation Medical ApS Financials, key figures and credit report
Gross profit 2 092.5 kDKK FY 2024 +248% vs 2023
EBIT 1 368.8 kDKK FY 2024 +128.3% vs 2023
Net debt -3 207.8 kDKK FY 2024 -1,120.3% vs 2023
Quick ratio 1.0 FY 2024 +0.2 vs 2023
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 498.95 | -1 412.35 | - 189.75 | -1 413.90 | 2 092.53 |
| Employee benefit expenses | -2 014.90 | -2 014.90 | - 723.73 | ||
| Other operating expenses | -0.51 | -1.34 | -1.57 | ||
| EBIT | 483.54 | -1 412.35 | - 191.09 | 599.43 | 1 368.81 |
| Other financial income | 57.43 | -12.43 | 37.31 | 80.76 | 4.67 |
| Other financial expenses | -37.25 | -7.85 | -70.92 | -43.65 | - 208.79 |
| Pre-tax profit | 503.73 | -1 432.63 | - 224.69 | 636.54 | 1 164.69 |
| Income taxes | - 111.47 | 307.77 | 45.23 | - 114.25 | - 287.41 |
| Net earnings | 392.25 | -1 124.86 | - 179.46 | 522.29 | 877.27 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Non-current loans receivable | 252.28 | 252.28 | 252.28 | 252.28 | 280.17 |
| Non-current other receivables | 1 001.52 | 710.11 | 645.62 | 458.41 | 402.14 |
| Long term receivables total | 1 253.81 | 962.40 | 897.91 | 710.69 | 682.31 |
| Inventories total | |||||
| Current trade debtors | 3 805.78 | 4 959.25 | 4 189.36 | 2 222.67 | 2 175.52 |
| Current amounts owed by group member comp. | 225.30 | 192.65 | 229.68 | 225.70 | |
| Current other receivables | 388.68 | 65.62 | 178.12 | 74.71 | 1 330.58 |
| Current deferred tax assets | 307.77 | 353.00 | 238.36 | ||
| Short term receivables total | 4 194.46 | 5 557.94 | 4 913.13 | 2 765.42 | 3 731.80 |
| Other current investments | 1 377.08 | 488.88 | 5 022.22 | ||
| Cash and bank deposits | 148.49 | 236.34 | 55.96 | 194.59 | 36.40 |
| Cash and cash equivalents | 148.49 | 236.34 | 1 433.04 | 683.47 | 5 058.62 |
| Balance sheet total (assets) | 5 596.76 | 6 756.68 | 7 244.08 | 4 159.58 | 9 472.73 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 0.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 107.00 | ||||
| Other reserves | 40.00 | ||||
| Retained earnings | 117.79 | 510.04 | - 614.82 | - 794.28 | - 271.99 |
| Profit of the financial year | 392.25 | -1 124.86 | - 179.46 | 522.29 | 877.27 |
| Shareholders equity total | 657.04 | - 574.82 | - 754.28 | - 231.99 | 645.28 |
| Non-current owed to group member | 2 014.90 | 2 014.90 | 2 014.90 | ||
| Non-current deferred tax liabilities | 48.66 | ||||
| Non-current liabilities total | 2 014.90 | 2 014.90 | 2 014.90 | 48.66 | |
| Current loans from credit institutions | -0.00 | -0.00 | |||
| Current trade creditors | 711.23 | 3 007.90 | 4 350.68 | 3 393.71 | 6 204.27 |
| Current owed to participating | 2 019.38 | 2 007.49 | 1 632.78 | 997.86 | 1 850.78 |
| Current owed to group member | 194.21 | 301.21 | |||
| Other non-interest bearing current liabilities | 0.00 | 723.73 | |||
| Current liabilities total | 2 924.82 | 5 316.60 | 5 983.46 | 4 391.58 | 8 778.78 |
| Balance sheet total (liabilities) | 5 596.76 | 6 756.68 | 7 244.08 | 4 159.58 | 9 472.73 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated